15 Both technologies are based on the CRISPR-Cas system but utilize different CRISPR-associated proteins, Cas13 for SHERLOCK and Cas12a for DETECTR, to achieve their highly specific diagnostic ...

Doudna spoke about all the new opportunities created by the development of the gene-editing tool CRISPR-Cas9. In March last year, Nice rejected Casgevy for people with severe sickle cell disease.

chemistry laureate Jennifer Doudna In her 2020 Nobel Prize lecture, Doudna spoke about all the new opportunities created by the development of the gene-editing tool CRISPR-Cas9. At the time Nice said ...

Emmanuelle Charpentier and Jennifer Doudna leveraged CRISPR into a pair of genetic scissors and showed how sharp they are by proving that they can edit any string of DNA this way. Since Emmanuelle ...